US EditionAtriCure’s AtriClip Pro-Mini Device Used in First Procedure After FDA Clearance - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
AtriCure’s AtriClip Pro-Mini Device Used in First Procedure After FDA Clearance - Cardiac Interventions Today
April 14, 2025—AtriCure, Inc. recently announced the first use of the AtriClip Pro-Mini left atrial appendage (LAA) exclusion system for minimally invasive concomitant procedures. The AtriClip Pro-Mini device, which received FDA 510(k) clearance earlier this year, builds upon AtriCure’s AtriClip platform of implanted surgical LAA devices, noted the company. According to AtriCure, the new AtriClip Pro-Mini is preloaded with a surgical LAA managem…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
